-
-
-
-
-
-
-
Simulations Plus teams with Lonza and FDA on drug prediction framework
-
-
-
-
-
-
-
BTIG Downgrades Simulations Plus (SLP) to Neutral
-
-
-
-
-
-
-
TD Cowen Starts Simulations Plus (SLP) at Hold
-
-
-
-
-
-
-
Simulations Plus invests $1 million in clinical trial technology firm Nurocor
-
-
-
-
-
-
-
Simulations Plus (SLP) PT Lowered to $41 at BTIG
-
-
-
-
-
-
-
Simulations Plus (SLP) and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
-
-
-
-
-
-
-
After-hours movers: Tesla, First Foundation, Simulations Plus, and Rivian
-
430,621 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

